Sofosbuvir
Sofosbuvir is a small molecule antiviral prodrug, metabolized to an active uridine analog that potently inhibits the HCV NS5B RNA-dependent RNA polymerase. It is a key research tool for studying HCV replication mechanisms and evaluating antiviral efficacy in both cellular and animal models of hepatitis C infection.
Product Specifications
CAS Number
1190307-88-0
Product Name Alternative
Sofosbuvir, PSI 7977, PSI7977, PSI-7977, Inhibitor, HCV Protease, HCV, Hepatitis C virus, HCVProtease, GS7977, GS-7977, GS 7977, inhibit
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.77% (May vary between batches)
Solubility
Ethanol:93 mg/mL (175.65 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.89 mM) ; DMSO:250 mg/mL (472.19 mM) ; H2O:9 mg/mL (17 mM)
Smiles
CC (C) OC (=O) [C@H] (C) NP (=O) (OC[C@H]1O[C@@H] (n2ccc (=O) [nH]c2=O) [C@] (C) (F) [C@@H]1O) Oc1ccccc1
Molecular Formula
C22H29FN3O9P
Molecular Weight
529.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Canine Ataxin-7-like protein 1 (ATXN7L1) ELISA Kit
Canine Ataxin-7-like protein 1 (ATXN7L1) ELISA Kit
Canine Ataxin-7-like protein 1 (ATXN7L1) ELISA Kit
Canine Ataxin-7-like protein 1 (ATXN7L1) ELISA Kit
